Briefly noted: A recent study (NM Gorgis et al. Hepatology 2019; 69: 1206-18, editorial 940-2 by Elizabeth Rand) indicates that cirrhotic cardiomyopathy (CCM) is very important factor for survival for biliary atresia (BA) patients requiring liver transplantation.
CCM was defined based on two-dimensional echocardiographic criteria: LV mass index ≥95 g/meter-squared or relative wall LV thickness of LV ≥0.42.
- Overall, 11 of 69 patients died, 4 while awaiting liver transplantation and 7 following transplantation.
- 34 of 69 BA patients in this cohort had BA-CCM
- All 11 who died had BA-CCM compared with no deaths in the 35 patients without CCM.
My take: Severe BA-CCM needs to be examined further; if severe, it may merit changing allocation policy.
Related blog posts:
Joshua Tree National Park
Briefly noted: M Izzy, J Oh, KD Watt. Hepatology 2018; 68: 2008-2015. This concise review discusses the outcome of cirrhotic cardiomyopathy after liver transplantation.
Key point: “Although it is often believed that cirrhotic cardiomyopathy resolves post-LT, the data, albeit limited, do not support this postulation…diastolic function may not improve post-transplant and may actually worsen. Improvement in systolic function was suggested by only two of six studies.”
Related blog post: Cholecardia
This figure from Hepatology November cover depicts a cirrhotic liver restricting the heart filling during diastole. (From Wiley Online Library -free access)
Cardiac changes with biliary atresia (BA) are surprisingly common– Gastoenterology 2011; 141: 1264-72. In this study, 48 patients with BA, listed for liver transplantation, underwent echocardiography between 2004-2010. The median age was 8 months. Significant increases in left ventricle wall thickness (23% increase) and mass (51% increase) were noted; in addition, functional changes were noted as there was an increase in LV shortening fraction (8% increase). Features of ‘cirrhotic cardiomyopathy’ were evident in 72% of infants (29/40). The authors conclude that these heart changes likely contribute to prolongation of posttransplant hospitalization.
- -J Am Coll Cardiol 2010; 56: 539-49
- -J Hepatol 2010; 53: 179-90.